middle.news
Island Pharmaceuticals Completes Phase 2b Enrollment in Dengue Trial
7:03pm on Monday 2nd of June, 2025 AEST
•
Pharmaceuticals
Read Story
Island Pharmaceuticals Completes Phase 2b Enrollment in Dengue Trial
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
All 10 subjects enrolled in Phase 2b therapeutic cohort of ISLA-101 trial
Phase 2b study tests ISLA-101’s ability to reduce symptoms in infected patients
Phase 2a cohort previously showed safety and antiviral activity
High-level Phase 2b results expected by April 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE